The Center for Rheumatology and Bone Research
Wheaton, Maryland, United States
Rheumatologist in Montgomery County, Maryland
2730 University Blvd W, Wheaton, MD 20902
About The Center for Rheumatology and Bone Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
17
Savient Pharmaceuticals
4
Bristol-Myers Squibb
3
Horizon Therapeutics Ireland DAC
3
R-Pharm International, LLC
3
Arthritis & Rheumatism Associates, P.C.
2
Astellas Pharma Inc
2
Galapagos NV
2
Genentech, Inc.
2
Human Genome Sciences Inc.
2
Novartis Pharmaceuticals
2
Clinical Trials at The Center for Rheumatology and Bone Research
During the past decade, The Center for Rheumatology and Bone Research conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 36 clinical trials were completed, i.e. on
average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 22 clinical trials were completed. i.e. 440%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate
2003-09-01
2006-04-01
Completed
300
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
2003-10-01
2006-06-01
Completed
449
A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
2004-03-01
2005-02-01
Completed
40
A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate
2004-06-01
2005-06-01
Completed
120
Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee
2005-04-01
2005-10-01
Completed
118
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus
2005-05-10
2008-08-25
Completed
262
TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
2000-04-27
2003-11-07
Completed
2,532
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Center for Rheumatology and Bone Research" #1 sponsor was "Pfizer" with 17 trials, followed by "Savient Pharmaceuticals" with 4 trials
sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Horizon Therapeutics Ireland DAC" with 3 trials sponsored and "R-Pharm International, LLC"
with 3 trials sponsored. Other sponsors include 36 different institutions and
companies that sponsored additional 38 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Center for Rheumatology and Bone Research"
#1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Affibody" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Columbia University" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at The Center for Rheumatology and Bone Research
According to Clinical.Site data, the most researched conditions in "The Center for Rheumatology and Bone Research" are
"Rheumatoid Arthritis" (17 trials), "Osteoarthritis" (9 trials), "Arthritis, Rheumatoid" (8 trials), "Gout" (6 trials) and "Arthritis" (5 trials). Many other conditions were trialed in "The Center for Rheumatology and Bone Research" in a lesser frequency.
Clinical Trials Intervention Types at The Center for Rheumatology and Bone Research
Most popular intervention types in "The Center for Rheumatology and Bone Research" are "Drug" (52 trials), "Biological" (18 trials), "Other" (9 trials), "Dietary Supplement" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Adalimumab" (4 trials), "Methotrexate" (4 trials), "Pegloticase" (4 trials) and "placebo" (4 trials). Other intervention names were less common.
Clinical Trials Genders at The Center for Rheumatology and Bone Research
The vast majority of trials in "The Center for Rheumatology and Bone Research" are
68 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at The Center for Rheumatology and Bone Research
Currently, there are NaN active trials in "The Center for Rheumatology and Bone Research".
undefined are not yet recruiting,
3 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 55 completed trials in The Center for Rheumatology and Bone Research,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in The Center for Rheumatology and Bone Research, 0 "Phase 1"
clinical trials were conducted, 21 "Phase 2" clinical
trials and 36 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 8 trials, and there were
also 2 trials that are defined as “Not Applicable".